FDA approves first new sickle cell drug in 20 years

(By Adam Feuerstein for STAT)

The FDA approved a new medicine Friday to reduce the complications associated with sickle cell disease, a rare blood disorder. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.